Kyowa Hakko Kirin Co., Ltd. announced the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the...
Read more
Takeda Pharmaceutical Company Limited announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16in its...
Read more
Glenmark Pharmaceuticals, a global pharmaceutical company announced positive results for GSP 301, an investigational fixed-dose combination of mometasone furoate (25...
Read more
Icertis, the leading provider of enterprise contract management in the cloud announced an upgrade to the Icertis Clinical Trial Agreement...
Read more
Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and...
Read more
Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an...
Read more
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from...
Read more
CohBar Inc , a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced...
Read more
Jazz Pharm announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110 , a...
Read moreNeuraltus Pharmaceuticals announced the confirmatory Phase 2 study of the Company’s lead investigational treatment NP001 for amyotrophic lateral sclerosis (ALS,...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
